Showing 1,459 news articles about Pharmaceutical industry

Filters Content type: Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Access to healthcare

“Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum

Editor's pick
Health Policy Watch
15 April 2019
Pharmaceutical industry

Will new TB treatments reach those who need them most?

Editor's pick
Devex
15 April 2019
Access to healthcare

Tackling the high price of medicine

Editor's pick
Daily Maverick
15 April 2019
Pharmaceutical industry

Dovato Is a Newly Approved Two-Drug HIV Regimen. Do Fewer Drugs Mean a Lower-Cost HIV Treatment?

Editor's pick
The Body
15 April 2019
Side effects

Gilead Lawsuits: 41 HIV and PrEP Patients File California Personal Injury Case Over Gilead's TDF-Based Drugs

Editor's pick
Associated Press
12 April 2019
Treatment simplification strategies

FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment

Editor's pick
Food & Drug Administration
9 April 2019
PrEP policies & guidelines

The CDC Director got shouted down by angry AIDS activists during a completely tone deaf speech

Editor's pick
LGBTQ Nation
5 April 2019
Pharmaceutical industry

Kenya steps up Aids battle as building starts on $100m drug factory

Editor's pick
The Guardian
29 March 2019
Pharmaceutical industry

Taxpayers funded this HIV research. The government patented it. Now a company profits.

Editor's pick
Los Angeles Times
29 March 2019
Hepatitis C treatment

Louisiana picks drug company for hepatitis C treatment plan

Editor's pick
San Francisco Chronicle
27 March 2019
PrEP policies & guidelines

PrEP Pricing Is the Elephant in the Room at the CDC National HIV Prevention Conference

Editor's pick
The Body
24 March 2019
Access to healthcare

Interview With Charles Gore, Medicines Patent Pool Executive Director

Editor's pick
Intellectual Property Watch
24 March 2019
New & experimental HIV treatments

Why 1 Top Analyst Thinks Gilead Sciences Will Soar More Than 25%

Editor's pick
Motley Fool
24 March 2019
Government, leadership & policy

Trump’s Proposed Budget Undermines His H.I.V. Plan, Experts Say

Editor's pick
The New York Times
14 March 2019
PrEP policies & guidelines

Gilead's Descovy snared its PrEP data, but can it stand up to Truvada generics?

Editor's pick
FiercePharma
14 March 2019
Finance & funding

Big Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes

Editor's pick
Kaiser Health News
5 March 2019
PrEP

Should the NIH Break HIV Prevention Drug Truvada's Patent?

Editor's pick
Fortune
5 March 2019
Pharmaceutical industry

Hepatitis C Treatment Market to Exceed US$ 71.13 Bn by the end of 2024

Editor's pick
Honest Businessman
4 March 2019
Finance & funding

A new way to pay for innovative drugs, provide universal access and not break the bank

Editor's pick
The Conversation
28 February 2019
Access to healthcare

Analysis: How a cutting edge medicine made it to South Africa’s new ARV tender

Editor's pick
Spotlight
27 February 2019
Access to healthcare

The Good Law Project threatens Judicial Review of Serious Shortage Protocols

Editor's pick
Good Law Project
24 February 2019
Access to healthcare

US: The struggle to maintain access to lifesaving HIV meds

Editor's pick
Washington Blade
24 February 2019
Pharmaceutical industry

The Trump Administration's Drug Pricing Proposals for People With HIV, Explained

Editor's pick
The Body
20 February 2019
Pharmaceutical industry

Trump's HIV pledge comes as Gilead pumps cash into Truvada for PrEP

Editor's pick
FiercePharma
7 February 2019